All Stories

  1. Toward personalized classification and treatment in depression: A narrative review of digital phenotyping and artificial intelligence
  2. Life Expectancy, Loss of Life Expectancy, and Lifetime Costs in Bipolar Disorder: A Nationwide Population‐Based Study
  3. Navigating the Digital Maze: A Review of AI Bias, Social Media, and Mental Health in Generation Z
  4. Omega-3 Fatty Acids and Neuroinflammation in Depression: Targeting Damage-Associated Molecular Patterns and Neural Biomarkers
  5. The Efficacy of Omega-3 Fatty Acids as the Monotherapy for Depression: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
  6. Omega-3 polyunsaturated fatty acids in the prevention of relapse in patients with stable bipolar disorder: A 6-month pilot randomized controlled trial
  7. Roles of Omega-3 Polyunsaturated Fatty Acids in Managing Cognitive Impairment in Chronic Obstructive Pulmonary Disease: A Review
  8. The Now and Future of ChatGPT and GPT in Psychiatry
  9. Personalized Medicine of Omega-3 Fatty Acids in Depression Treatment in Obese and Metabolically Dysregulated Patients
  10. Personalized Medicine of Omega-3 Fatty Acids in Depression Treatment in Obese and Metabolically Dysregulated Patients
  11. Psychological Outcomes and Quality of Life of Fibromyalgia Patients with Vitamin D Supplementation—A Meta-Analysis
  12. Omega-3 Polyunsaturated Fatty Acids in Managing Comorbid Mood Disorders in Chronic Obstructive Pulmonary Disease (COPD): A Review
  13. The Clinical Observation of Inflammation Theory for Depression: The Initiative of the Formosa Long COVID Multicenter Study (FOCuS)
  14. Identification of Genetic Variations in the NAD-Related Pathways for Patients with Major Depressive Disorder: A Case-Control Study in Taiwan
  15. Personalised medicine in child and Adolescent Psychiatry: Focus on omega-3 polyunsaturated fatty acids and ADHD
  16. Cortisol and inflammatory biomarker levels in youths with attention deficit hyperactivity disorder (ADHD): evidence from a systematic review with meta-analysis
  17. Efficacy and acceptability of different interventions for acrophobia: A network meta-analysis of randomised controlled trials
  18. Challenges and opportunities for early career child mental health professionals during the COVID19 pandemic
  19. Nutritional Neuroscience as Mainstream of Psychiatry: The Evidence- Based Treatment Guidelines for Using Omega-3 Fatty Acids as a New Treatment for Psychiatric Disorders in Children and Adolescents
  20. Plasma estradiol levels and antidepressant effects of omega-3 fatty acids in pregnant women
  21. Somatic pain associated with initiation of interferon-alpha (IFN-α) plus ribavirin (RBV) therapy in chronic HCV patients: A prospective study
  22. High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels
  23. Major depressive episodes during pregnancy and after childbirth: A prospective longitudinal study in Taiwan
  24. Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: An open-label pilot study
  25. Atypical major depressive episode as initial presentation of intracranial germinoma in a male adolescent
  26. Polyunsaturated fatty acids levels and initial presentation of somatic symptoms induced by interferon-alpha therapy in patients with chronic hepatitis C viral infection
  27. Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression
  28. Omega-3 Fatty Acids in the Prevention of Interferon-Alpha-Induced Depression: Results from a Randomized, Controlled Trial
  29. Serotonin-Norepinephrine Reuptake Inhibitor–Associated Mixed Episode in an Adolescent With Schizoaffective Disorder
  30. View on DSM from Taiwan: transition from IV to 5
  31. Maternal parenting styles and mother–child relationship among adolescents with and without persistent attention-deficit/hyperactivity disorder
  32. Serotonin-Norepinephrine Reuptake Inhibitor Treatment for Tinnitus and Depression
  33. Introducing the concept of modern depression in Japan; an international case vignette survey
  34. Early detection and management of atypical neuroleptic malignant syndrome secondary to aripiprazole
  35. Does the ‘hikikomori’ syndrome of social withdrawal exist outside Japan? A preliminary international investigation
  36. Omega-3 Polyunsaturated Fatty Acids (PUFAs) as the "Mind-Body Interface" in Cardiovascular Diseases and Depression
  37. A case of venlafaxine-induced bruxism alleviated by duloxetine substitution
  38. A Case of Milnacipran-Related Sweating Alleviated by Duloxetine Substitution
  39. Reliability and validity of three Chinese-version tasks of Mayer-Salovey-Caruso Emotional Intelligence Test
  40. Paliperidone overdose in a patient with schizophrenia
  41. Emotional management and 5-HT2A receptor gene variance in patients with schizophrenia
  42. Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) in Cardiovascular Diseases (CVDs) and Depression: The Missing Link?
  43. Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) treatment for Isaacs syndrome with depression